Drug Interaction Report

Metformin and Vandetanib: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Vandetanib

Caprelsa Caprelsa®
+

Metformin

Fortamet® Glucophage Glucophage® Glumetza Glumetza® Riomet Riomet® Trijardy® (as a combination product containing Empagliflozin, Linagliptin, Metformin)
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 378 documented Metformin interactions, 99 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
unspecified
Evidence
established
Severity
Major

What happens

Increased metFORMIN exposure and an increased risk of lactic acidosis

Interaction Deep Dive

Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metFORMIN eg, organic cationic transporter-2 (OCT 2)/ multidrug and toxin extrusion (MATE) inhibitors such as vandetanib may result in increased metFORMIN exposure and may increase the risk for lactic acidosis1. During a drug interaction study in health volunteers, coadministration of metFORMIN and vandetanib resulted in an increase in metFORMIN AUC and Cmax. Therefore, if coadministration is required, use caution and monitor patient for metFORMIN toxicity 3. Consider the benefits and risks of concomitant use 2.

Why it happens (mechanism)

Inhibition of organic cation transporter 2 (OCT 2); inhibition of multidrug and toxin extrusion transporter MATE 1-mediated renal elimination of metFORMIN; inhibition of MATE 2-mediated renal elimination of metFORMIN

Literature reports

1 report — tap to read

a) During a crossover, single-dose study of 13 healthy volunteers, administration of oral metFORMIN 1000 mg 3 hours after oral vandetanib 800 mg resulted in a 74% and 50% increase in metFORMIN AUC and Cmax, respectively, compared with metFORMIN alone 3.

Common questions

Can I take Metformin and Vandetanib together?

Increased metFORMIN exposure and an increased risk of lactic acidosis Always confirm with your pharmacist or prescriber before making any change.

How serious is the Metformin and Vandetanib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

From our Q&A

Real reader questions about these medications, each personally answered by our pharmacist:

Questions for your pharmacist

  • Does my dose of Metformin or Vandetanib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: SYNJARDY(R) oral tablets, empagliflozin metformin hydrochloride oral tablets. Boehringer Ingelheim Pharmaceuticals Inc (per FDA), Ridgefield, CT, 2025. DailyMed
  2. Product Information: KAZANO oral tablets, alogliptin, metformin hydrochloride oral tablets. Takeda Pharmaceuticals America Inc (per FDA), Lexington, MA, 2023. DailyMed
  3. Product Information: CAPRELSA(R) oral tablets, vandetanib oral tablets. Genzyme Corporation (per FDA), Cambridge, MA, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.